Takeda Pharmaceutical SG&A Expense (Quarterly) Insights

Takeda Pharmaceutical Co Ltd (TAK)

13.37 +0.10 (+0.75%) USD | NYSE | May 03, 16:00

13.36 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	1.812B
September 30, 2023	1.751B
June 30, 2023	1.808B
March 31, 2023	1.929B
December 31, 2022	1.861B
September 30, 2022	1.801B
June 30, 2022	1.786B
March 31, 2022	1.923B
December 31, 2021	2.033B
September 30, 2021	1.926B
June 30, 2021	2.008B
March 31, 2021	2.213B
December 31, 2020	2.132B
September 30, 2020	2.038B
June 30, 2020	1.881B
March 31, 2020	2.324B
December 31, 2019	2.292B
September 30, 2019	2.081B
June 30, 2019	2.176B
March 31, 2019	2.451B
December 31, 2018	1.365B
September 30, 2018	1.335B

Date	Value
June 30, 2018	1.330B
March 31, 2018	1.585B
December 31, 2017	1.409B
September 30, 2017	1.365B
June 30, 2017	1.313B
March 31, 2017	1.580B
December 31, 2016	1.360B
September 30, 2016	1.426B
June 30, 2016	1.342B
March 31, 2016	1.521B
December 31, 2015	1.334B
September 30, 2015	1.242B
June 30, 2015	1.333B
March 31, 2015	1.465B
December 31, 2014	1.354B
September 30, 2014	1.410B
June 30, 2014	1.337B
March 31, 2014	1.530B
December 31, 2013	1.377B
September 30, 2013	1.324B
June 30, 2013	1.312B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.751B

Minimum

Sep 2023

2.324B

Maximum

Mar 2020

1.988B

Average

1.929B

Median

Mar 2023

SG&A Expense (Quarterly) Benchmarks